DSCYX
Price
$30.43
Change
-$0.58 (-1.87%)
Updated
Jun 13 closing price
Net Assets
216.87M
NAESX
Price
$111.80
Change
-$0.14 (-0.13%)
Updated
Jun 12 closing price
Net Assets
147.56B
Interact to see
Advertisement

DSCYX vs NAESX

Header iconDSCYX vs NAESX Comparison
Open Charts DSCYX vs NAESXBanner chart's image
BNY Mellon Opportunistic Small Cap Y
Price$30.43
Change-$0.58 (-1.87%)
VolumeN/A
Net Assets216.87M
Vanguard Small Cap Index I
Price$111.80
Change-$0.14 (-0.13%)
VolumeN/A
Net Assets147.56B
DSCYX vs NAESX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DSCYX vs. NAESX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSCYX is a Buy and NAESX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NAESX has more cash in the bank: 148B vs. DSCYX (217M). NAESX pays higher dividends than DSCYX: NAESX (1.35) vs DSCYX (0.78). DSCYX was incepted earlier than NAESX: DSCYX (9 years) vs NAESX (65 years). DSCYX (0.86) is less costly to investors than NAESX (0.17). DSCYX is a more actively managed with annual turnover of: 61.03 vs. NAESX (13.00). DSCYX has a lower initial minimum investment than NAESX: DSCYX (0) vs NAESX (3000). NAESX annual gain was more profitable for investors over the last year : 6.18 vs. DSCYX (3.51). NAESX return over 5 years is better than : 66.07 vs. DSCYX (33.31).
DSCYXNAESXDSCYX / NAESX
Total Expense Ratio0.760.17447%
Annual Report Gross Expense Ratio0.860.17506%
Fund Existence9 years65 years-
Gain YTD-0.513-2.70419%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets217M148B0%
Annual Yield % from dividends0.781.3558%
Returns for 1 year3.516.1857%
Returns for 3 years8.8133.0627%
Returns for 5 years33.3166.0750%
Returns for 10 yearsN/A97.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCUS9.24-0.11
-1.18%
Arcus Biosciences
NNBR1.93-0.03
-1.53%
NN
ALGN177.85-3.84
-2.11%
Align Technology
GMS76.03-1.77
-2.28%
GMS
OVID0.28-0.01
-3.15%
Ovid Therapeutics